In blow to Shire, Roche bags an FDA OK for its blockbuster hemophilia A prospect
Despite being dogged by questions about safety and an unusual legal counterattack from rival Shire, Roche today scored an FDA approval for emicizumab (ACE910), its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.